Global Choroidal Neovascularization Market Size By Segmentations, Top Key Players, Trend, Future Development & Forecast 2024-2035
- PUBLISHED ON
- 11/23/2022
- NO OF PAGES
- 216
- CATEGORY
- Healthcare & Life Sciences
The competitive landscape analysis of Choroidal Neovascularization Market uncovers detailed company profiles, revenue shares, portfolio innovations, regional product footprint, key developmental strategies, pricing structure, target markets, and near-term plans of market leaders. This entire section helps readers gain an essence of what is driving competition and what would help them stand out to win new target markets.
Market estimates and forecast are backed by an extensive primary research, further complemented by on-point secondary research of Choroidal Neovascularization Market. The research analysts have invested significant time and effort in gathering critical industry information from KIPs such as OEMs, top suppliers and distributors, and government bodies.
Market Segmentations:
The research report includes specific segments by region (country), by Company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Global Choroidal Neovascularization Market: By Types
Intravenous
Intravitreal
Global Choroidal Neovascularization Market: By Applications
Extreme Myopia
Malignant Myopic Degeneration
Age-Related Developments
By Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
Global Choroidal Neovascularization Market: Top Key Players
Pfizer Inc.
F. Hoffmann-La Roche Ltd.
Novartis AG
Regeneron Pharmaceuticals Inc.
Bayer AG
QLT Inc.
Sanwa Kagaku Kenkyusho Co. Ltd.
Promedior Inc.
Bausch Health
Gilead Sciences Inc
Global Choroidal Neovascularization Market: Market Size Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets of various marketspaces. The key players in the markets are identified through secondary research, and their market contributions in different applications across regions and globally were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to arrive at the final quantitative and qualitative data. This data has been consolidated, and detailed inputs and analysis from Analytics Market Research added before being presented in this report.
Reasons to Purchase Choroidal Neovascularization Market Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
Frequently Asked Questions
• What is the market size and growth projections?
• What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?
• What are the top performing segments, and countries / regions of each of the markets?
• What is the market size and growth rate across key countries / regions?
• How big is the global & regional market in terms of revenue and volume?
• How far market will grow in forecast period in terms of revenue and volume?
• What factors will influence demand and supply trends across each markets during the forecast period?
• What are the technology trends shaping various markets?
• Which country / region has more opportunities?
• What is the COVID-19 impact on the market and how long will it take to recover?
• Who are the key competitors of market Players?
• What are the market share (%) of Key Players?
• What are the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?
• What are PEST analysis, Ecosystem Analysis, Porter's Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?
Base Year: 2023Market estimates and forecast are backed by an extensive primary research, further complemented by on-point secondary research of Choroidal Neovascularization Market. The research analysts have invested significant time and effort in gathering critical industry information from KIPs such as OEMs, top suppliers and distributors, and government bodies.
Market Segmentations:
The research report includes specific segments by region (country), by Company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Global Choroidal Neovascularization Market: By Types
Intravenous
Intravitreal
Global Choroidal Neovascularization Market: By Applications
Extreme Myopia
Malignant Myopic Degeneration
Age-Related Developments
By Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
Global Choroidal Neovascularization Market: Top Key Players
Pfizer Inc.
F. Hoffmann-La Roche Ltd.
Novartis AG
Regeneron Pharmaceuticals Inc.
Bayer AG
QLT Inc.
Sanwa Kagaku Kenkyusho Co. Ltd.
Promedior Inc.
Bausch Health
Gilead Sciences Inc
Global Choroidal Neovascularization Market: Market Size Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets of various marketspaces. The key players in the markets are identified through secondary research, and their market contributions in different applications across regions and globally were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to arrive at the final quantitative and qualitative data. This data has been consolidated, and detailed inputs and analysis from Analytics Market Research added before being presented in this report.
Reasons to Purchase Choroidal Neovascularization Market Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
Frequently Asked Questions
• What is the market size and growth projections?
• What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?
• What are the top performing segments, and countries / regions of each of the markets?
• What is the market size and growth rate across key countries / regions?
• How big is the global & regional market in terms of revenue and volume?
• How far market will grow in forecast period in terms of revenue and volume?
• What factors will influence demand and supply trends across each markets during the forecast period?
• What are the technology trends shaping various markets?
• Which country / region has more opportunities?
• What is the COVID-19 impact on the market and how long will it take to recover?
• Who are the key competitors of market Players?
• What are the market share (%) of Key Players?
• What are the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?
• What are PEST analysis, Ecosystem Analysis, Porter's Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?
Historic Year: 2016-2022
Forecast: 2024-2035
1 Choroidal Neovascularization Market Overview
1.1 Product Overview and Scope of Choroidal Neovascularization
1.2 Choroidal Neovascularization Segment by Type
1.2.1 Global Choroidal Neovascularization Sales Growth Rate Comparison by Type (2022-2030)
1.2.2 Intravenous
1.2.3 Intravitreal
1.3 Choroidal Neovascularization Segment by Application
1.3.1 Choroidal Neovascularization Sales Comparison by Application: (2022-2030)
1.3.2 Extreme Myopia
1.3.3 Malignant Myopic Degeneration
1.3.4 Age-Related Developments
1.4 Global Choroidal Neovascularization Market Size Estimates and Forecasts
1.4.1 Global Choroidal Neovascularization Revenue 2016-2030
1.4.2 Global Choroidal Neovascularization Sales 2016-2030
1.4.3 Choroidal Neovascularization Market Size by Region: 2016 Versus 2022 Versus 2030
2 Choroidal Neovascularization Market Competition by Manufacturers
2.1 Global Choroidal Neovascularization Sales Market Share by Manufacturers (2016-2021)
2.2 Global Choroidal Neovascularization Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Choroidal Neovascularization Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Choroidal Neovascularization Manufacturing Sites, Area Served, Product Type
2.5 Choroidal Neovascularization Market Competitive Situation and Trends
2.5.1 Choroidal Neovascularization Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Choroidal Neovascularization Players Market Share by Revenue
2.5.3 Global Choroidal Neovascularization Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Choroidal Neovascularization Retrospective Market Scenario by Region
3.1 Global Choroidal Neovascularization Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Choroidal Neovascularization Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Choroidal Neovascularization Market Facts & Figures by Country
3.3.1 North America Choroidal Neovascularization Sales by Country
3.3.2 North America Choroidal Neovascularization Revenue by Country
3.3.3 United States
3.3.4 Canada
3.3.3 Mexico
3.4 Europe Choroidal Neovascularization Market Facts & Figures by Country
3.4.1 Europe Choroidal Neovascularization Sales by Country
3.4.2 Europe Choroidal Neovascularization Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 UK
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Choroidal Neovascularization Market Facts & Figures by Region
3.5.1 Asia Pacific Choroidal Neovascularization Sales by Region
3.5.2 Asia Pacific Choroidal Neovascularization Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Indonesia
3.5.9 Thailand
3.5.10 Malaysia
3.5.11 Philippines
3.5.12 Vietnam
3.6 Latin America Choroidal Neovascularization Market Facts & Figures by Country
3.6.1 Latin America Choroidal Neovascularization Sales by Country
3.6.2 Latin America Choroidal Neovascularization Revenue by Country
3.6.3 Brazil
3.7 Middle East and Africa Choroidal Neovascularization Market Facts & Figures by Country
3.7.1 Middle East and Africa Choroidal Neovascularization Sales by Country
3.7.2 Middle East and Africa Choroidal Neovascularization Revenue by Country
3.7.3 Turkey
3.7.4 GCC Countries
3.7.5 Egypt
3.7.6 South Africa
4 Global Choroidal Neovascularization Historic Market Analysis by Type
4.1 Global Choroidal Neovascularization Sales Market Share by Type (2016-2021)
4.2 Global Choroidal Neovascularization Revenue Market Share by Type (2016-2021)
4.3 Global Choroidal Neovascularization Price by Type (2016-2021)
5 Global Choroidal Neovascularization Historic Market Analysis by Application
5.1 Global Choroidal Neovascularization Sales Market Share by Application (2016-2021)
5.2 Global Choroidal Neovascularization Revenue Market Share by Application (2016-2021)
5.3 Global Choroidal Neovascularization Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Pfizer Inc.
6.1.1 Pfizer Inc. Corporation Information
6.1.2 Pfizer Inc. Description and Business Overview
6.1.3 Pfizer Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Pfizer Inc. Product Portfolio
6.1.5 Pfizer Inc. Recent Developments/Updates
6.2 F. Hoffmann-La Roche Ltd.
6.2.1 F. Hoffmann-La Roche Ltd. Corporation Information
6.2.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
6.2.3 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Sales, Revenue and Gross Margin (2016-2021)
6.2.4 F. Hoffmann-La Roche Ltd. Product Portfolio
6.2.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
6.3 Novartis AG
6.3.1 Novartis AG Corporation Information
6.3.2 Novartis AG Description and Business Overview
6.3.3 Novartis AG Choroidal Neovascularization Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Novartis AG Product Portfolio
6.3.5 Novartis AG Recent Developments/Updates
6.4 Regeneron Pharmaceuticals Inc.
6.4.1 Regeneron Pharmaceuticals Inc. Corporation Information
6.4.2 Regeneron Pharmaceuticals Inc. Description and Business Overview
6.4.3 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Regeneron Pharmaceuticals Inc. Product Portfolio
6.4.5 Regeneron Pharmaceuticals Inc. Recent Developments/Updates
6.5 Bayer AG
6.5.1 Bayer AG Corporation Information
6.5.2 Bayer AG Description and Business Overview
6.5.3 Bayer AG Choroidal Neovascularization Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Bayer AG Product Portfolio
6.5.5 Bayer AG Recent Developments/Updates
6.6 QLT Inc.
6.6.1 QLT Inc. Corporation Information
6.6.2 QLT Inc. Description and Business Overview
6.6.3 QLT Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2016-2021)
6.6.4 QLT Inc. Product Portfolio
6.6.5 QLT Inc. Recent Developments/Updates
6.7 Sanwa Kagaku Kenkyusho Co. Ltd.
6.6.1 Sanwa Kagaku Kenkyusho Co. Ltd. Corporation Information
6.6.2 Sanwa Kagaku Kenkyusho Co. Ltd. Description and Business Overview
6.6.3 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sanwa Kagaku Kenkyusho Co. Ltd. Product Portfolio
6.7.5 Sanwa Kagaku Kenkyusho Co. Ltd. Recent Developments/Updates
6.8 Promedior Inc.
6.8.1 Promedior Inc. Corporation Information
6.8.2 Promedior Inc. Description and Business Overview
6.8.3 Promedior Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Promedior Inc. Product Portfolio
6.8.5 Promedior Inc. Recent Developments/Updates
6.9 Bausch Health
6.9.1 Bausch Health Corporation Information
6.9.2 Bausch Health Description and Business Overview
6.9.3 Bausch Health Choroidal Neovascularization Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Bausch Health Product Portfolio
6.9.5 Bausch Health Recent Developments/Updates
6.10 Gilead Sciences Inc
6.10.1 Gilead Sciences Inc Corporation Information
6.10.2 Gilead Sciences Inc Description and Business Overview
6.10.3 Gilead Sciences Inc Choroidal Neovascularization Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Gilead Sciences Inc Product Portfolio
6.10.5 Gilead Sciences Inc Recent Developments/Updates
7 Choroidal Neovascularization Manufacturing Cost Analysis
7.1 Choroidal Neovascularization Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Choroidal Neovascularization
7.4 Choroidal Neovascularization Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Choroidal Neovascularization Distributors List
8.3 Choroidal Neovascularization Customers
9 Choroidal Neovascularization Market Dynamics
9.1 Choroidal Neovascularization Industry Trends
9.2 Choroidal Neovascularization Growth Drivers
9.3 Choroidal Neovascularization Market Challenges
9.4 Choroidal Neovascularization Market Restraints
10 Global Market Forecast
10.1 Choroidal Neovascularization Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Choroidal Neovascularization by Type (2022-2030)
10.1.2 Global Forecasted Revenue of Choroidal Neovascularization by Type (2022-2030)
10.2 Choroidal Neovascularization Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Choroidal Neovascularization by Application (2022-2030)
10.2.2 Global Forecasted Revenue of Choroidal Neovascularization by Application (2022-2030)
10.3 Choroidal Neovascularization Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Choroidal Neovascularization by Region (2022-2030)
10.3.2 Global Forecasted Revenue of Choroidal Neovascularization by Region (2022-2030)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
1.1 Product Overview and Scope of Choroidal Neovascularization
1.2 Choroidal Neovascularization Segment by Type
1.2.1 Global Choroidal Neovascularization Sales Growth Rate Comparison by Type (2022-2030)
1.2.2 Intravenous
1.2.3 Intravitreal
1.3 Choroidal Neovascularization Segment by Application
1.3.1 Choroidal Neovascularization Sales Comparison by Application: (2022-2030)
1.3.2 Extreme Myopia
1.3.3 Malignant Myopic Degeneration
1.3.4 Age-Related Developments
1.4 Global Choroidal Neovascularization Market Size Estimates and Forecasts
1.4.1 Global Choroidal Neovascularization Revenue 2016-2030
1.4.2 Global Choroidal Neovascularization Sales 2016-2030
1.4.3 Choroidal Neovascularization Market Size by Region: 2016 Versus 2022 Versus 2030
2 Choroidal Neovascularization Market Competition by Manufacturers
2.1 Global Choroidal Neovascularization Sales Market Share by Manufacturers (2016-2021)
2.2 Global Choroidal Neovascularization Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Choroidal Neovascularization Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Choroidal Neovascularization Manufacturing Sites, Area Served, Product Type
2.5 Choroidal Neovascularization Market Competitive Situation and Trends
2.5.1 Choroidal Neovascularization Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Choroidal Neovascularization Players Market Share by Revenue
2.5.3 Global Choroidal Neovascularization Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Choroidal Neovascularization Retrospective Market Scenario by Region
3.1 Global Choroidal Neovascularization Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Choroidal Neovascularization Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Choroidal Neovascularization Market Facts & Figures by Country
3.3.1 North America Choroidal Neovascularization Sales by Country
3.3.2 North America Choroidal Neovascularization Revenue by Country
3.3.3 United States
3.3.4 Canada
3.3.3 Mexico
3.4 Europe Choroidal Neovascularization Market Facts & Figures by Country
3.4.1 Europe Choroidal Neovascularization Sales by Country
3.4.2 Europe Choroidal Neovascularization Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 UK
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Choroidal Neovascularization Market Facts & Figures by Region
3.5.1 Asia Pacific Choroidal Neovascularization Sales by Region
3.5.2 Asia Pacific Choroidal Neovascularization Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Indonesia
3.5.9 Thailand
3.5.10 Malaysia
3.5.11 Philippines
3.5.12 Vietnam
3.6 Latin America Choroidal Neovascularization Market Facts & Figures by Country
3.6.1 Latin America Choroidal Neovascularization Sales by Country
3.6.2 Latin America Choroidal Neovascularization Revenue by Country
3.6.3 Brazil
3.7 Middle East and Africa Choroidal Neovascularization Market Facts & Figures by Country
3.7.1 Middle East and Africa Choroidal Neovascularization Sales by Country
3.7.2 Middle East and Africa Choroidal Neovascularization Revenue by Country
3.7.3 Turkey
3.7.4 GCC Countries
3.7.5 Egypt
3.7.6 South Africa
4 Global Choroidal Neovascularization Historic Market Analysis by Type
4.1 Global Choroidal Neovascularization Sales Market Share by Type (2016-2021)
4.2 Global Choroidal Neovascularization Revenue Market Share by Type (2016-2021)
4.3 Global Choroidal Neovascularization Price by Type (2016-2021)
5 Global Choroidal Neovascularization Historic Market Analysis by Application
5.1 Global Choroidal Neovascularization Sales Market Share by Application (2016-2021)
5.2 Global Choroidal Neovascularization Revenue Market Share by Application (2016-2021)
5.3 Global Choroidal Neovascularization Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Pfizer Inc.
6.1.1 Pfizer Inc. Corporation Information
6.1.2 Pfizer Inc. Description and Business Overview
6.1.3 Pfizer Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Pfizer Inc. Product Portfolio
6.1.5 Pfizer Inc. Recent Developments/Updates
6.2 F. Hoffmann-La Roche Ltd.
6.2.1 F. Hoffmann-La Roche Ltd. Corporation Information
6.2.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
6.2.3 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Sales, Revenue and Gross Margin (2016-2021)
6.2.4 F. Hoffmann-La Roche Ltd. Product Portfolio
6.2.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
6.3 Novartis AG
6.3.1 Novartis AG Corporation Information
6.3.2 Novartis AG Description and Business Overview
6.3.3 Novartis AG Choroidal Neovascularization Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Novartis AG Product Portfolio
6.3.5 Novartis AG Recent Developments/Updates
6.4 Regeneron Pharmaceuticals Inc.
6.4.1 Regeneron Pharmaceuticals Inc. Corporation Information
6.4.2 Regeneron Pharmaceuticals Inc. Description and Business Overview
6.4.3 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Regeneron Pharmaceuticals Inc. Product Portfolio
6.4.5 Regeneron Pharmaceuticals Inc. Recent Developments/Updates
6.5 Bayer AG
6.5.1 Bayer AG Corporation Information
6.5.2 Bayer AG Description and Business Overview
6.5.3 Bayer AG Choroidal Neovascularization Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Bayer AG Product Portfolio
6.5.5 Bayer AG Recent Developments/Updates
6.6 QLT Inc.
6.6.1 QLT Inc. Corporation Information
6.6.2 QLT Inc. Description and Business Overview
6.6.3 QLT Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2016-2021)
6.6.4 QLT Inc. Product Portfolio
6.6.5 QLT Inc. Recent Developments/Updates
6.7 Sanwa Kagaku Kenkyusho Co. Ltd.
6.6.1 Sanwa Kagaku Kenkyusho Co. Ltd. Corporation Information
6.6.2 Sanwa Kagaku Kenkyusho Co. Ltd. Description and Business Overview
6.6.3 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sanwa Kagaku Kenkyusho Co. Ltd. Product Portfolio
6.7.5 Sanwa Kagaku Kenkyusho Co. Ltd. Recent Developments/Updates
6.8 Promedior Inc.
6.8.1 Promedior Inc. Corporation Information
6.8.2 Promedior Inc. Description and Business Overview
6.8.3 Promedior Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Promedior Inc. Product Portfolio
6.8.5 Promedior Inc. Recent Developments/Updates
6.9 Bausch Health
6.9.1 Bausch Health Corporation Information
6.9.2 Bausch Health Description and Business Overview
6.9.3 Bausch Health Choroidal Neovascularization Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Bausch Health Product Portfolio
6.9.5 Bausch Health Recent Developments/Updates
6.10 Gilead Sciences Inc
6.10.1 Gilead Sciences Inc Corporation Information
6.10.2 Gilead Sciences Inc Description and Business Overview
6.10.3 Gilead Sciences Inc Choroidal Neovascularization Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Gilead Sciences Inc Product Portfolio
6.10.5 Gilead Sciences Inc Recent Developments/Updates
7 Choroidal Neovascularization Manufacturing Cost Analysis
7.1 Choroidal Neovascularization Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Choroidal Neovascularization
7.4 Choroidal Neovascularization Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Choroidal Neovascularization Distributors List
8.3 Choroidal Neovascularization Customers
9 Choroidal Neovascularization Market Dynamics
9.1 Choroidal Neovascularization Industry Trends
9.2 Choroidal Neovascularization Growth Drivers
9.3 Choroidal Neovascularization Market Challenges
9.4 Choroidal Neovascularization Market Restraints
10 Global Market Forecast
10.1 Choroidal Neovascularization Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Choroidal Neovascularization by Type (2022-2030)
10.1.2 Global Forecasted Revenue of Choroidal Neovascularization by Type (2022-2030)
10.2 Choroidal Neovascularization Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Choroidal Neovascularization by Application (2022-2030)
10.2.2 Global Forecasted Revenue of Choroidal Neovascularization by Application (2022-2030)
10.3 Choroidal Neovascularization Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Choroidal Neovascularization by Region (2022-2030)
10.3.2 Global Forecasted Revenue of Choroidal Neovascularization by Region (2022-2030)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.
}})
Pricing
Select a license type that suits your business needs
Single User Access
US $3950
Only Three Thousand Nine Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
Multi User Cost
US $4950
Only Four Thousand Nine Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
Enterprise User Cost
US $5950
Only Five Thousand Nine Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI